Thermochemotherapy_in_inoperable_head_and_neck_cancer._A_combined_hyperthermia_and_chemotherapy_approach_was_used_to_treat_five_patients_with_locally_advanced_or_recurrent_squamous_cell_carcinoma_of_the_head_and_neck_whose_tumors_had_failed_to_respond_to_chemotherapy._In_two_patients,_tumor_had_recurred_after_initial_combined_modality_therapy_(surgery/radiation)_and_had_failed_to_respond_to_one_course_of_cisplatin/5-fluorouracil_(cisplatin/5-FU)_chemotherapy._The_three_remaining_patients_were_enrolled_onto_a_phase_II_evaluation_of_induction_chemotherapy_with_cisplatin/fluorouracil_for_advanced_head_and_neck_carcinomas_and_had_failed_to_achieve_a_partial_remission_after_one_treatment_cycle._Palpable_cervical_tumors_were_heated_to_40_degrees_to_42_degrees_C_for_30_to_40_minutes,_during_which_time_cisplatin_(100_mg/m2)_was_infused_intravenously._A_5-day_infusion_of_5-fluorouracil_(1000_mg/m2/d)_followed._Despite_less_than_a_partial_response_to_previous_cisplatin/fluorouracil_chemotherapy_alone,_two_patients_had_complete_clinical_resolution_of_the_heated_tumor_volume_with_two_cycles_of_the_combined_thermochemotherapy_approach._One_patient_achieved_a_partial_remission_with_this_approach._The_remaining_two_patients_died_shortly_after_the_initial_thermochemotherapy_treatment,_as_a_result_of_progressive_tumor_growth._The_two_complete_responders_were_subsequently_treated_with_radiation_(1_patient)_and_radical_neck_dissection_(1_patient)_and_remained_without_evidence_of_disease_2_and_26_months_after_the_completion_of_therapy,_respectively._The_toxicity_of_this_combined_modality_approach_was_acceptable_and_appeared_to_be_no_greater_than_had_been_experienced_during_earlier_treatment_with_chemotherapy_alone._Further_studies_using_a_combination_of_these_treatment_modalities_for_locally_advanced_head_and_neck_carcinomas_are_warranted.